Psilocybin and Bipolar Depression: Promise and Prudence
No abstract is available for this record.
Bibliographic context
Topics and keywords
psilocybin DepressionChronic PainPharmacologyClinical TrialToxicity Clinical Trial Bipolar disorderPsilocybinPsychiatryPsychologyPrudenceAntidepressantDepression (economics)PsychopharmacologyMedicineClinical trialTreatment of bipolar disorderPsychotherapistSchizophrenia (object-oriented programming)AnhedoniaQuetiapineMajor depressive disorderHypomaniaNeurologyMental healthClinical psychology
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depressionJournal of Affective Disorders · 2026-02-11Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapyJournal of Affective Disorders · 2025-12-16Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depressionJournal of Affective Disorders · 2026-06-03Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysisJournal of Affective Disorders · 2026-03-21Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trialJournal of Affective Disorders · 2026-02-15Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot studyJournal of Affective Disorders · 2024-09-26Pharmacodynamic biomarker - or psychotherapeutic process? Comment on “The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression”Journal of Affective Disorders · 2025-11-10